LONDON (Reuters) - Roche Holding AG believes it has moved into pole position in the race to develop an Alzheimer's drug that can change the course of the disease after its rivals suffered setbacks in the past month.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/W8CbZjsOVvU/us-alzheimers-roche-trial-idUSBRE8860JO20120907
phlebotomy certification chicago phlebotomy training bay area free phlebotomy training
No comments:
Post a Comment